NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.915 USD | -5.67% | +60.83% | +89.22% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.22% | 23.91M | |
+2.85% | 108B | |
+10.14% | 105B | |
+1.57% | 23.46B | |
-12.15% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.32% | 17.19B | |
+6.26% | 13.99B | |
+36.09% | 12.53B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023